NASDAQ · ACHC
Acadia Healthcare Company, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for ACHC: Nov 04, 2026
Acadia Healthcare Company, Inc. Common Stock is expected to report earnings on 11/04/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 5 analysts' forecasts, the consensus EPS forecast for the quarter is $0.46. The reported EPS for the same quarter last year was $0.72.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $0.46 | $0.49 | $0.43 | 5 |
| Dec 2026 | $0.35 | $0.41 | $0.27 | 4 |
| Mar 2027 | $0.31 | $0.33 | $0.28 | 2 |
| Jun 2027 | $0.41 | $0.41 | $0.41 | 2 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks- Zacks · Oct 29, 11:06 AM EDTGRAIL Q3 Earnings Ahead: Galleri Test Adoption to Drive GrowthGRAL's Q3 earnings should have benefited from rising Galleri test adoption, expanding digital health partnerships and growing clinical evidence of cancer detection.
- Zacks · Oct 29, 7:35 AM EDTTenet Healthcare (THC) Surpasses Q3 Earnings and Revenue EstimatesTenet (THC) delivered earnings and revenue surprises of +44.35% and +2.87%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Oct 28, 9:27 AM EDTEnvista Q3 Earnings Ahead: Product Innovation to Drive GrowthNVST's Q3 earnings may have gained from Spark aligner growth, new product launches and improving margins. Can innovation drive another earnings beat?
- Zacks · Oct 27, 8:21 AM EDTHenry Schein to Report Q3 Earnings: Here's What You Should KnowHSIC gears up for Q3 earnings with revenue growth expected across its three segments, fueled by dental products, specialty demand and cloud-based technology.
- Zacks · Oct 26, 8:58 AM EDTCareDx to Report Q3 Earnings: Transplant Testing Growth in FocusCareDx's Q3 earnings are in focus as transplant testing growth, stronger reimbursement and oncology expansion drive revenue prospects despite potential margin pressures.
- Zacks · Oct 23, 7:19 AM EDTHere's How IDEXX Laboratories Is Placed Ahead of Q3 EarningsIDXX heads into Q3 earnings with expected revenue and EPS growth, fueled by CAG Diagnostics momentum, higher testing volumes and software gains.
- Zacks · Oct 22, 8:08 AM EDTAlign Technology to Report Q3 Earnings: What's in the Cards?ALGN's Q3 earnings may benefit from Clear Aligner growth and digital innovations, while capital equipment market challenges could weigh on results.
- Zacks · Oct 21, 9:45 AM EDTDHR Q3 Earnings Beat on Biotechnology Strength, Sales in LineDanaher's third-quarter earnings beat estimates by 9.9%, driven by stronger Biotechnology profitability, while it raised its 2026 adjusted earnings outlook.
- Zacks · Oct 21, 8:28 AM EDTLabcorp Prepares to Report Q3 Earnings: What's in the Cards?LH's Q3 earnings may benefit from strong diagnostics demand, specialty testing expansion and acquisitions, with revenues projected to grow 5.7%.
- Zacks · Oct 16, 11:42 AM EDTCan Molina Healthcare Overcome Lower Premiums and Higher MCR in Q3?MOH faces a tough Q3 as declining premiums, shrinking membership and a higher medical care ratio threaten earnings. Can it beat expectations?
- Zacks · Oct 16, 8:41 AM EDTDanaher Gears Up to Post Q3 Earnings: What Lies Ahead for the Stock?DHR's Q3 results are due Oct. 21, with growth in Biotechnology, Diagnostics and Life Sciences expected to boost revenues, while rising costs and currency headwinds weigh on earnings.
- Zacks · Oct 15, 9:31 AM EDTElevance Q3 Earnings Preview: Will Lower Premiums Weigh on Results?Can ELV overcome a 4.9% premium decline and weaker Health Benefits income? Membership losses add pressure, though higher product revenues may offer some relief.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Acadia Healthcare Company, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.